Lv3
217 积分 2023-05-18 加入
Integrating China’s Oncology Innovations into the Global Landscape: A Strategic Blueprint for Precision, Partnership, and Purpose
2个月前
已完结
Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial
3个月前
已完结
Neoadjuvant pamiparib plus abiraterone and androgen deprivation therapy for high-risk/very high-risk localized prostate cancer: an open-label, single-arm, phase 2 study
3个月前
已完结
Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer
4个月前
已完结
The SDC1-ENO1 Axis in Cancer-Associated Fibroblasts Generates a Lactate-Rich Microenvironment that Drives Tumor Radioresistance
4个月前
已完结
Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Phase 2 Study
4个月前
已完结
Expression of Membrane Targets for Therapeutics in RET-Positive Non–Small Cell Lung Cancer
7个月前
已完结
Elucidating the Cell Surfaceome to Accelerate Cancer Drug Development
7个月前
已完结
Targeting the tumour cell surface in advanced prostate cancer
7个月前
已完结
Neoadjuvant pamiparib plus abiraterone and androgen deprivation therapy for high-risk/very high-risk localized prostate cancer: an open-label, single-arm, phase 2 study
8个月前
已关闭
皖公网安备34019202002308
